
Nymox Pharmaceutical Corporation NYMX
Geschäftsbericht 2024
hinzugefügt 13.12.2025
Nymox Pharmaceutical Corporation Finanzkreislauf 2011-2025 | NYMX
Finanzkreislauf Jährlich Nymox Pharmaceutical Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | -2.39 K | -4.07 K | -2.85 K | -945 | -1.13 K | -731 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -731 | -4.07 K | -2.02 K |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Amphastar Pharmaceuticals
AMPH
|
166 | $ 25.27 | -2.43 % | $ 1.22 B | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
31.5 | $ 4.75 | 1.61 % | $ 788 M | ||
|
Aclaris Therapeutics
ACRS
|
-881 | $ 3.26 | -3.12 % | $ 252 M | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-2.85 K | - | -11.43 % | $ 502 K | ||
|
Kamada Ltd.
KMDA
|
163 | $ 7.03 | 0.14 % | $ 260 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
-193 | $ 0.91 | -5.01 % | $ 18.7 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
AstraZeneca PLC
AZN
|
-58 | $ 89.78 | -0.57 % | $ 96.9 B | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
Anika Therapeutics
ANIK
|
270 | $ 9.57 | 0.84 % | $ 140 M | ||
|
Brickell Biotech
BBI
|
149 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
214 | - | -7.31 % | $ 87 M | ||
|
Benitec Biopharma
BNTC
|
141 | $ 12.05 | -7.06 % | $ 496 M | ||
|
Aytu BioScience
AYTU
|
174 | $ 2.34 | 2.59 % | $ 14.7 M | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
Aptorum Group Limited
APM
|
-400 | $ 1.29 | -3.01 % | $ 7.03 M | ||
|
Baudax Bio
BXRX
|
-14.3 | - | 0.59 % | $ 63 K | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Catalyst Biosciences
CBIO
|
391 | $ 14.01 | -8.49 % | $ 922 M | ||
|
ChromaDex Corporation
CDXC
|
23.8 | - | -0.88 % | $ 598 M | ||
|
Axon Enterprise
AXON
|
86.2 | $ 566.18 | -2.56 % | $ 42.9 B | ||
|
Cerus Corporation
CERS
|
59.2 | $ 2.16 | 0.47 % | $ 399 M | ||
|
Caladrius Biosciences
CLBS
|
164 | - | -16.75 % | $ 25.8 M | ||
|
Clovis Oncology
CLVS
|
65.5 | - | -7.23 % | $ 13 M | ||
|
Biogen
BIIB
|
387 | $ 174.42 | 1.11 % | $ 25.4 B | ||
|
Celldex Therapeutics
CLDX
|
-6.08 K | $ 27.36 | -2.09 % | $ 1.76 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
-101 | - | - | $ 2.18 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
209 | $ 11.54 | 0.87 % | $ 746 M |